Literature DB >> 3496952

Complex translocation t(8;12;14) in a cell line derived from a child with nonendemic Burkitt-type acute lymphoblastic leukemia.

E Nacheva, P Fischer, A Karpas, P Sherrington, F G Hayhoe, G Manolov, Y Manolova, G Ferstl, O Haas, H Gadner.   

Abstract

A cell line is described with a typical Burkitt lymphoma (BL) marker 14q+ due to the classical reciprocal translocation between chromosome #8 and #14 with breakpoints at 8q24.1 and 14q32.3. In addition, an interstitial piece from the long arm of 12(q24.1-q24.3) is inserted at the site of the exchange on chromosome #8, proximal to 14q32.3.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3496952     DOI： 10.1016/0165-4608(87)90364-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


  3 in total

1.  Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.

Authors:  Carlos Baliñas-Gavira; María I Rodríguez; Alvaro Andrades; Marta Cuadros; Juan Carlos Álvarez-Pérez; Ángel F Álvarez-Prado; Virginia G de Yébenes; Sabina Sánchez-Hernández; Elvira Fernández-Vigo; Javier Muñoz; Francisco Martín; Almudena R Ramiro; José A Martínez-Climent; Pedro P Medina
Journal:  Leukemia       Date:  2020-06-24       Impact factor: 11.528

2.  The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker.

Authors:  M J Keen; C Hale
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

3.  Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells.

Authors:  W Rowan; J Tite; P Topley; S J Brett
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.